Goodwin Procter advised Envisagenics, Inc. on the deal. Envisagenics, Inc. announced a research collaboration agreement with Bristol Myers Squibb Company (NYSE: BMY). The multi-year collaboration will leverage...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised The Boeing Company on the deal. The Fifth Circuit awarded a complete victory to The Boeing Company, and its co-defendant Southwest Airlines, in a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the underwriters on the deal. Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised OpenAI Startup Fund on the deal. OpenAI Startup Fund announced its investment in Descript’s $50 million Series C financing round to support and accelerate...
You must be a Standard 1 Year member to access this content.
LOSCHELDER advised the International Campus Group (IC) on the deal while Goodwin has advised “The FIZZ Student Housing SCS”. IC is a leading investor, developer and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Octopus Ventures and BGF on the deal. Octopus Ventures and BGF announced their investment in a £40 million Series C financing round in...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Redpoint Ventures and Madrona Venture Group on the deal. Redpoint Ventures and Madrona Venture Group led the MotherDuck’s $12.5 million seed funding round. Redpoint...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Redpoint Ventures on the deal. Redpoint Ventures led Omni’s $17.5 million Series A financing. Redpoint invests in startups across the seed, early and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised FogPharma® on the deal. FogPharma® announced its $178 Million Series D financing. FogPharma is a biopharmaceutical company pioneering a new class of precision...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Centerview Partners on the deal, Latham & Watkins represented Imago BioSciences, Gibson Dunn & Crutcher advised Merck. Merck (NYSE: MRK) and Imago BioSciences, Inc....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Needham & Company on the deal. SkyWater Technology, Inc. announced the offering of its common stock for an aggregate amount of $17.25 million. The...
You must be a Standard 1 Year member to access this content.
Goodwin advised WESAKE on the deal. WESAKE announced its partnership with Brooklyn Peltz Beckham, who joined the company as a co-founder and partner. WESAKE partners with a...
You must be a Standard 1 Year member to access this content.
